AR107948A2
Desmopressin in an orodispersible dosage form
Abstract
Claim 1: An orodispersible pharmaceutical dosage form of desmopressin acetate characterized in that it disintegrates in the mouth within 10 seconds. Claim 10: A process for preparing a pharmaceutical dosage form as set forth in any of claims 2 or 3, characterized in that it comprises sublimating the solvent of a composition comprising desmopressin acetate and a solution of carrier material in the solvent, wherein the Composition is in solid form in a mold.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
2 claims: 2 independent, 0 dependent
- 11:Una forma de dosificación farmacéutica orodispersable de acetato de desmopresina caracterizada porque se desintegra en la boca dentro de los 10 segundos.
- 1010:Un proceso para preparar una forma de dosificación farmacéutica como se indica en cualquiera de las reivindicaciones 2 ó 3, caracterizado porque comprende sublimar el solvente de una composición que comprende acetato de desmopresina y una solución de material vehículo en el solvente, donde la composición se encuentra en estado sólido en un molde.
Independent claims2
84 members in 30 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 02103976 | United Kingdom | – | |
| 0210397 | United Kingdom | A | |
| TIB2002004036 | World Intellectual Property Organization (WIPO) | – |
Members84
| Document | Office | Kind | |
|---|---|---|---|
| GB0210397D0 | United Kingdom | D0 | |
| AU2002337419A1 | Australia | A1 | |
| AU2003233118A1 | Australia | A1 | |
| CA2484724A1 | Canada | A1 | |
| WO03094885A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO03094886A2 | World Intellectual Property Organization (WIPO) | A2 | |
| UY27796A1 | Uruguay | A1 | |
| UY27683A1 | Uruguay | A1 | |
| TW200400054A | Taiwan Province of China | A | |
| WO2004041153A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003299480A1 | Australia | A1 | |
| AU2003299480A8 | Australia | A8 | |
| US2004138098A1 | United States of America | A1 | |
| WO03094886A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2004041153A3 | World Intellectual Property Organization (WIPO) | A3 | |
| KR20050009999A | Republic of Korea | A | |
| EP1501534A2 | European Patent Office (EPO) | A2 | |
| NO20045345L | Norway | L | |
| AR039092A1 | Argentina | A1 | |
| MXPA04010926A | Mexico | A | |
| BR0309819A | Brazil | A | |
| AR039794A1 | Argentina | A1 | |
| HRP20041152A2 | Croatia | A2 | |
| CN1649615A | China | A | |
| RU2004130435A | Russian Federation | A | |
| US2005232997A1 | United States of America | A1 | |
| HK1074393A | Hong Kong, China | A | |
| HK1074393A1 | Hong Kong, China | A1 | |
| PL375497A1 | Poland | A1 | |
| IL164519A0 | Israel | A0 | |
| IL164519D0 | Israel | D0 | |
| JP2006502972A | Japan | A | |
| ZA200408596B | South Africa | B | |
| EP1501534B1 | European Patent Office (EPO) | B1 | |
| AT333886T | Austria | T | |
| ATE333886T1 | Austria | T1 | |
| DE60307082D1 | Germany | D1 | |
| PT1501534E | Portugal | E | |
| KR100632455B1 | Republic of Korea | B1 | |
| AU2003233118B2 | Australia | B2 | |
| DK1501534T3 | Denmark | T3 | |
| NZ535861A | New Zealand | A | |
| SI1501534T1 | Slovenia | T1 | |
| CA2484724C | Canada | C | |
| DE60307082T2 | Germany | T2 | |
| RU2292903C2 | Russian Federation | C2 | |
| ES2266820T3 | Spain | T3 | |
| CN1319592C | China | C | |
| CN1981745A | China | A | |
| MY131153A | Malaysia | A | |
| US2007265207A1 | United States of America | A1 | |
| HRP20041152B1 | Croatia | B1 | |
| US7405203B2 | United States of America | B2 | |
| US2008274951A1 | United States of America | A1 | |
| US2009005432A1 | United States of America | A1 | |
| UA85664C2 | Ukraine | C2 | |
| US7560429B2 | United States of America | B2 | |
| AU2003233118B8 | Australia | B8 | |
| US7579321B2 | United States of America | B2 | |
| IL164519A | Israel | A | |
| TWI315202B | Taiwan Province of China | B | |
| US2009318665A1 | United States of America | A1 | |
| US2010056436A1 | United States of America | A1 | |
| US7799761B2 | United States of America | B2 | |
| US7947654B2 | United States of America | B2 | |
| PL208482B1 | Poland | B1 | |
| US2012071538A1 | United States of America | A1 | |
| US8143225B2 | United States of America | B2 | |
| US2012322734A1 | United States of America | A1 | |
| US8802624B2 | United States of America | B2 | |
| NO335167B1 | Norway | B1 | |
| DK1501534T5 | Denmark | T5 | |
| ES2266820T4 | Spain | T4 | |
| DE60307082T4 | Germany | T4 | |
| US2015150938A1 | United States of America | A1 | |
| US9220747B2 | United States of America | B2 | |
| US2016175246A1 | United States of America | A1 | |
| US9504647B2 | United States of America | B2 | |
| US2017112895A1 | United States of America | A1 | |
| US9919025B2 | United States of America | B2 | |
| AR107948A2This record | Argentina | A2 | |
| US2018280469A1 | United States of America | A1 | |
| US10307459B2 | United States of America | B2 | |
| US2021161810A1 | United States of America | A1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| RefusalFC | FC |
Numbers
- Publication
- 107948
- Application
- 160100416
Titles2
- Spanish
- FORMULACIONES FARMACÉUTICAS
- English
- PHARMACEUTICAL FORMULATIONS
Classification
- CPC, 22
- A61K9/0056
- A61K9/00
- A61K47/42
- A61K9/2013
- A61K9/2018
- A61K9/2063
- A61K9/2095
- A61K38/095
- A61K38/12
- A61P1/12
- A61P13/00
- A61P13/02
- A61P13/10
- A61P7/00
- A61P7/08
- A61P7/10
- A61P7/12
- A61P3/10
- A61K9/20
- A61K38/08
- A61K47/12
- A61K47/26
- IPC, 7
- A61K38 11
- A61K47 12
- A61K47 26
- A61K47 42
- A61K9 00
- A61K9 20
- A61K38 095